Table I.
|
M-2RT-PCR
|
M-3RT-PCR
|
M-33RT-PCR
|
M-41DNA-PCR
|
M-42DNA-PCR
|
M-43DNA-PCR
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | n | % | |
Amplification:b | ||||||||||||
TCR-β+ cells | 91 | 63.2 | 114 | 79.2 | 115 | 79.9 | 70 | 54.7 | 62 | 48.4 | 79 | 41.1 |
TCR-α1 cells | 76 | 52.8 | 91 | 63.2 | 58 | 40.3 | 85 | 66.4 | 70 | 54.7 | 135 | 70.3 |
Total cells amplified | 144 | 144 | 144 | 128 | 128 | 192 | ||||||
Cells with seq's for:c | ||||||||||||
CW3-TCR-β | 78 | 54.2 | 114 | 79.2 | 115 | 79.9 | nae | na | na | na | na | na |
CW3-TCR-α | 71 | 49.3 | 90 | 62.5 | 57 | 39.6 | na | na | na | na | na | na |
CW3-αβ TCR | 48 | 33.3 | 79 | 54.9 | 45 | 31.2 | 46 | 35.9 | 37 | 28.9 | 57 | 29.7 |
No. of different CW3-TCRs:d | ||||||||||||
αβ TCRs | 15 | 18 | 10 | 15 | 11 | 16 | ||||||
Additional TCR-β's | 1 | 3 | 5 | na | na | na | ||||||
Additional TCR-α's | 3 | 0 | 0 | na | na | na |
2 wk after immunization with P815-CW3 transfectants, Vβ10+CD8 T cells gated as CD62L− (M-2 and M-3) or pCW3Kd+ (M-33, M-41, M-42, and M-43) were sorted as single cells and TCR sequences were amplified by RT-PCR or DNA-PCR.
The number and percent of cells for which a TCR-β or TCR-α sequence was amplified.
The number and percent of cells for which a CW3-like TCR-β, TCR-α, or paired αβ TCR was amplified.
The number of different CW3-like αβ TCRs and the number of additional CW3-like TCR-β or TCR-α sequences found without a partner.
Not applicable because we only determined sequences for cells from which both a TCR-α and TCR-β PCR product was detected.